Source: Eur Respir Monogr 2017; 75: 185-205
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Eva Van Braeckel, Menno M. van der Eerden. Long-term oral antibiotic treatment: why, what, when and to whom?. Eur Respir Monogr 2017; 75: 185-205

Member's Comments

No comment yet.

Related content which might interest you: TB vaccination: why, when, how and what? Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 Positional therapy: who, when and how? Source: Sleep and Breathing Conference 2021 Year: 2021 Eradication and long-term antibiotic treatment: does it make sense? Source: International Congress 2014 – PG08 The management of non-CF bronchiectasis: from childhood to adulthood Year: 2014 TB following targeted and biological therapy: can we predict it? Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 What do new data concerning triple therapy tell us about the risk of infection? Source: International Congress 2019 – Exploring the link between inhaled corticosteroids and respiratory infection Year: 2019 Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it tolerable? Is it easy to take? What do our patients think? Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 Pharmacotherapy of CSA: who, when and how? Source: Sleep and Breathing Conference 2021 Year: 2021 Immunotherapy: when, who and which drug? Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer Year: 2018 What’s new in induction therapy Source: ERS Course 2016 Year: 2016 Cleaning agents and asthma: what does the evidence currently tell us about diagnosis and management of these cases? Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health? Year: 2018 Antifungals in pulmonary infections: to whom, when and how? Source: Eur Respir Monogr 2017; 75: 159-184 Year: 2017 How often do asthma patients claim prescribed therapy? Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS Year: 2017 Optimising bronchodilator therapy in COPD: Who, why and when? Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care Year: 2019 What happens when an oral tuberculosis is not treated? Source: Annual Congress 2007 - Clinical tuberculosis Year: 2007 Macrolide therapy in asthma: limited treatment, long-term improvement Source: Eur Respir J 2009; 33: 1239 Year: 2009 Evaluating disease-modifying treatment in CF: are we ready to take the challenge? Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases" Year: 2014